N-(4-pyridyl) methyl carbamate inhibits fast potassium currents in guinea pig dorsal root ganglion cells

[1]  R. Shi,et al.  4-Aminopyridine derivatives enhance impulse conduction in guinea-pig spinal cord following traumatic injury , 2007, Neuroscience.

[2]  P. Pasricha,et al.  Enhanced excitability and suppression of A-type K+ current of pancreas-specific afferent neurons in a rat model of chronic pancreatitis. , 2006, American journal of physiology. Gastrointestinal and liver physiology.

[3]  S. Waxman,et al.  Molecular Reconstruction of Nodes of Ranvier after Remyelination by Transplanted Olfactory Ensheathing Cells in the Demyelinated Spinal Cord , 2006, The Journal of Neuroscience.

[4]  C. Bever,et al.  Potassium channel blockers in multiple sclerosis: neuronal Kv channels and effects of symptomatic treatment. , 2006, Pharmacology & therapeutics.

[5]  R. Shi,et al.  Dose responses of three 4-aminopyridine derivatives on axonal conduction in spinal cord trauma. , 2006, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[6]  R H LaMotte,et al.  Effects of a chronic compression of the dorsal root ganglion on voltage-gated Na+ and K+ currents in cutaneous afferent neurons. , 2006, Journal of neurophysiology.

[7]  C. Bever,et al.  Voltage-gated potassium channels in multiple sclerosis: Overview and new implications for treatment of central nervous system inflammation and degeneration. , 2006, Journal of rehabilitation research and development.

[8]  R. Shi,et al.  Development of novel 4-aminopyridine derivatives as potential treatments for neurological injury and disease. , 2005, European journal of medicinal chemistry.

[9]  H. Pan,et al.  A-type voltage-gated K+ currents influence firing properties of isolectin B4-positive but not isolectin B4-negative primary sensory neurons. , 2005, Journal of neurophysiology.

[10]  S. Whittemore,et al.  Functional and electrophysiological changes after graded traumatic spinal cord injury in adult rat , 2005, Experimental Neurology.

[11]  J. Hsieh,et al.  Pharmacokinetics and safety of multiple oral doses of sustained-release 4-aminopyridine (Fampridine-SR) in subjects with chronic, incomplete spinal cord injury. , 2004, Archives of physical medicine and rehabilitation.

[12]  Aminopyridine-sensitivity of spinal cord white matter studied in vitro , 1985, Experimental Brain Research.

[13]  Elior Peles,et al.  The local differentiation of myelinated axons at nodes of Ranvier , 2003, Nature Reviews Neuroscience.

[14]  S. Vanner,et al.  Ileitis modulates potassium and sodium currents in guinea pig dorsal root ganglia sensory neurons , 2003, The Journal of physiology.

[15]  R. Shi,et al.  Effects of 4-aminopyridine on stretched mammalian spinal cord: the role of potassium channels in axonal conduction. , 2003, Journal of neurophysiology.

[16]  D. Wolfe,et al.  Pharmacokinetics of an Immediate‐Release Oral Formulation of Fampridine (4‐Aminopyridine) in Normal Subjects and Patients with Spinal Cord Injury , 2003, Journal of clinical pharmacology.

[17]  C. Polman,et al.  Randomized trial of 4-aminopyridine in patients with chronic incomplete spinal cord injury , 2001, Journal of Neurology.

[18]  J. Segal,et al.  Safety and Efficacy of 4‐Aminopyridine in Humans with Spinal Cord Injury: A Long‐Term, Controlled Trial , 1999, Pharmacotherapy.

[19]  K. Fujihara,et al.  The effects of 4-aminopyridine on motor evoked potentials in multiple sclerosis , 1998, Journal of the Neurological Sciences.

[20]  J. Kocsis,et al.  Morphologically identified cutaneous afferent DRG neurons express three different potassium currents in varying proportions. , 1998, Journal of neurophysiology.

[21]  T. M. Kelly,et al.  Conduction Block in Acute and Chronic Spinal Cord Injury: Different Dose–Response Characteristics for Reversal by 4-Aminopyridine , 1997, Experimental Neurology.

[22]  A. Blight,et al.  Differential effects of low and high concentrations of 4-aminopyridine on axonal conduction in normal and injured spinal cord , 1997, Neuroscience.

[23]  A. Blight,et al.  Compression injury of mammalian spinal cord in vitro and the dynamics of action potential conduction failure. , 1996, Journal of neurophysiology.

[24]  D. Wolfe,et al.  4-Aminopyridine-sensitive neurologic deficits in patients with spinal cord injury. , 1994, Journal of neurotrauma.

[25]  R. Hoffman,et al.  Characterization of 4-aminopyridine in overdose. , 1994, Journal of Toxicology Clinical Toxicology.

[26]  P. Akins,et al.  Characterization of potassium currents in adult rat sensory neurons and modulation by opioids and cyclic AMP , 1993, Neuroscience.

[27]  P. Schwartzkroin,et al.  Heteromultimeric K+ channels in terminal and juxtaparanodal regions of neurons , 1993, Nature.

[28]  C. Polman,et al.  4-Aminopyridine induces functional improvement in multiple sclerosis patients: A neurophysiological study , 1993, Journal of the Neurological Sciences.

[29]  E. Cooper,et al.  Kinetics and voltage dependence of A-type currents on neonatal rat sensory neurons. , 1991, Journal of neurophysiology.

[30]  A. Blight,et al.  The effects of 4-aminopyridine on neurological deficits in chronic cases of traumatic spinal cord injury in dogs: a phase I clinical trial. , 1991, Journal of neurotrauma.

[31]  C. Schauf,et al.  4‐Aminopyridine improves clinical signs in multiple sclerosis , 1987, Annals of neurology.

[32]  A. Blight,et al.  Morphometric analysis of experimental spinal cord injury in the cat: The relation of injury intensity to survival of myelinated axons , 1986, Neuroscience.

[33]  Richard P. Bunge,et al.  Electron Microscopic Study of Demyelination in an Experimentally Induced Lesion in Adult Cat Spinal Cord , 1960, The Journal of biophysical and biochemical cytology.